TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 OVERVIEW OF EUROPE RADIOTHERAPY MARKET
1.3 CURRENCY AND PRICING
1.3.1 LIMITATION
1.3.2 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET CHALLENGE MATRIX
2.8 SECONDARY SOURCES
2.9 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 GROWING INCIDNECE OF CANCER
3.1.2 RISING AGEING POPULATION
3.1.3 UNHEALTHY LIFESTYLE
3.1.4 MERGERS AND ACQUISITIONS TO EXPAND BUSINESS
3.2 RESTRAINTS
3.2.1 REGULATORY SCENARIO
3.2.2 HIGH COST OF RADIOTHERAPY
3.3 OPPORTUNITIES
3.3.1 EMERGING MARKET
3.4 CHALLENGES
3.4.1 SIDE-EFFECTS OF RADIOTHERAPY
3.4.2 REQUIREMENT OF TRAINED STAFF
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 INCREASING GOVERNMENT FUNDING AND TECHNOLOGICAL ADVANCEMENT IS EXPECTED TO DRIVE THE MARKET FOR RADIOTHERAPY IN THE FORECAST PERIOD 2018 TO 2025
6 EUROPE RADIOTHERAPY MARKET, BY THERAPY TYPE
6.1 OVERVIEW
6.2 BEAM RADIOTHERAPY
6.2.1 IGRT
6.2.2 IMRT
6.2.3 STEREOTACTIC TECHNOLOGY
6.2.4 TOMOTHERAPY
6.2.5 3D CONFORMAL RADIOTHERAPY
6.2.6 VMAT
6.3 BRACHYTHERAPY
6.3.1 LDR
6.3.2 HDR
6.4 SYSTEMIC RADIOTHERAPY
7 EUROPE RADIOTHERAPY MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 EXTERNAL BEAM RADIOTHERAPY
7.2.1 LINAC
7.2.2 CYBER KNIFE
7.2.3 PROTON THERAPY
7.2.3.1 CYCLOTRON
7.2.3.2 SYNCLOTRON
7.2.4 GAMMA KNIFE
7.3 INTERNAL RADIOTHERAPY PRODUCTS
7.3.1 SEEDS
7.3.2 AFTERLOADERS
7.4 RADIOTHERAPY SOFTWARE
7.4.1 TREATMENT PLANNING SOFTWARE
7.4.2 DOSAGE PLANNING SOFTWARE
7.4.3 PATIENT POSITIONING SOFTWARE
7.4.4 IMAGE GUIDING SOFTWARE
7.5 SYSTEMIC RADIOTHERAPY
8 EUROPE RADIOTHERAPY MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 PROSTATE CANCER
8.3 BREAST CANCER
8.4 LUNG CANCER
8.5 SPINE CANCER
8.6 LIVER CANCER
8.7 BRAIN CANCER
8.8 OTHERS
9 EUROPE RADIOTHERAPY MARKET, BY GEOGRAPHY
9.1 EUROPE
9.1.1 GERMANY
9.1.2 U.K.
9.1.3 FRANCE
9.1.4 ITALY
9.1.5 SPAIN
9.1.6 SWITZERLAND
9.1.7 NETHERLANDS
9.1.8 BELGIUM
9.1.9 RUSSIA
9.1.10 TURKEY
9.1.11 REST OF EUROPE
10 EUROPE RADIOTHERAPY MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS; EUROPE
11 COMPANY PROFILES
11.1 VARIAN MEDICAL SYSTEMS, INC.
11.1.1 COMPANY OVERVIEW
11.1.2 REVENUE ANALYSIS
11.1.3 PRODUCT PORTFOLIO
11.2 ELEKTA AB
11.2.1 COMPANY OVERVIEW
11.2.2 REVENUE ANALYSIS
11.2.3 PRODUCT PORTFOLIO
11.2.4 RECENT DEVELOPMENTS
11.3 ACCURAY, INC.
11.3.1 COMPANY OVERVIEW
11.3.2 REVENUE ANALYSIS
11.3.3 PRODUCT PORTFOLIO
11.3.4 RECENT DEVELOPMENTS
11.4 BRAINLAB AG
11.4.1 COMPANY OVERVIEW
11.4.2 PRODUCT PORTFOLIO
11.4.3 RECENT DEVELOPMENTS
11.5 ION BEAM APPLICATIONS SA
11.5.1 COMPANY OVERVIEW
11.5.2 REVENUE ANALYSIS
11.5.3 PRODUCT PORTFOLIO
11.5.4 RECENT DEVELOPMENTS
11.6 ISORAY MEDICAL, INC.
11.6.1 COMPANY OVERVIEW
11.6.2 PRODUCT PORTFOLIO
11.6.3 RECENT DEVELOPMENTS
11.6.4 RECENT DEVELOPMENTS
11.7 MEVION MEDICAL SYSTEMS, INC.
11.7.1 COMPANY OVERVIEW
11.7.2 PRODUCT PORTFOLIO
11.7.3 RECENT DEVELOPMENTS
11.8 NANOBIOTIX
11.8.1 COMPANY OVERVIEW
11.8.2 REVENUE ANALYSIS
11.8.3 PRODUCT PORTFOLIO
11.8.4 RECENT DEVELOPMENTS
11.9 NORDION (CANADA) INC.
11.9.1 COMPANY OVERVIEW
11.9.2 PRODUCT PORTFOLIO
11.9.3 RECENT DEVELOPMENTS
11.10 PRECISIS AG
11.10.1 COMPANY OVERVIEW
11.10.2 PRODUCT PORTFOLIO
11.10.3 RECENT DEVELOPMENTS
11.11 RAYSEARCH LABORATORIES AB
11.11.1 COMPANY OVERVIEW
11.11.2 REVENUE ANALYSIS
11.11.3 PRODUCT PORTFOLIO
11.11.4 RECENT DEVELOPMENTS
12 RELATED REPORTS